...
首页> 外文期刊>Clinics in dermatology >Current technologies for the in vivo diagnosis of cutaneous melanomas.
【24h】

Current technologies for the in vivo diagnosis of cutaneous melanomas.

机译:用于皮肤黑色素瘤的体内诊断的当前技术。

获取原文
获取原文并翻译 | 示例
           

摘要

The rising incidence of cutaneous malignant melanoma has been observed in the past decades. Currently, there is no cure for metastatic melanoma; only early diagnosis followed by prompt excision of cutaneous lesions ensures a good prognosis. The clinical ABCD rule is created as a framework for differentiating melanomas from benign pigmented skin lesions, and it serves as the basis for current clinical diagnosis. The ABCD rule relies on four simple clinical morphologies of melanoma: 1) Asymmetry, 2) Border irregularity, 3) Color variegation, and 4) Diameter greater than 6 mm. Although it is valuable, it has its limitations. Currently, the diagnostic accuracy for physicians is about 65%. This statistic implies that 1) melanomas with subtle signs are missed as benign lesions, and 2) benign lesions are over diagnosed as melanomas, which lead to unnecessary biopsies.
机译:在过去的几十年中,皮肤恶性黑色素瘤的发病率不断上升。目前,尚无治愈转移性黑色素瘤的方法。只有早期诊断并及时切除皮肤病变才能确保良好的预后。创建临床ABCD规则是将黑色素瘤与良性色素性皮肤病变区分开来的框架,它是当前临床诊断的基础。 ABCD规则依赖于黑色素瘤的四种简单临床形态:1)不对称,2)边界不规则,3)颜色多样化和4)直径大于6毫米。尽管它很有价值,但是它有其局限性。当前,医生的诊断准确性约为65%。该统计数字表明:1)良性病变错过了黑色素瘤的征兆,2)良性病变被过度诊断为黑色素瘤,这导致不必要的活检。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号